IPD — ImpediMed Cashflow Statement
0.000.00%
Last trade - 00:00- AU$83.13m
- AU$75.43m
- AU$12.72m
- 33
- 23
- 77
- 40
Annual cashflow statement for ImpediMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -13.8 | -18.8 | -19.7 | -21.7 | -18.9 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -13.3 | -15.7 | -18 | -17.8 | -14.6 |
| Capital Expenditures | -2.46 | -5.22 | -6.04 | -3.1 | -0.989 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -2.46 | -5.22 | -6.04 | -3.1 | -0.989 |
| Financing Cash Flow Items | -0.133 | -2.21 | -1.67 | -0.062 | -1.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.5 | 39.9 | 27.9 | -0.481 | 13.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.018 | 21 | 4.98 | -21.1 | -2.45 |